Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
82 |
|
| Actual shortage: | 12 (15%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 69 (84%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 3 (75%) | |
| Discontinued: | 1 (25%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (19%) |
|
Overdue reports |
9 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | Resolved | 2018-08-10 | 2019-02-20 | 57888 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2018-05-02 | 2018-05-16 | 48144 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2022-01-28 | 2022-07-22 | 153839 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Resolved | 2018-03-08 | 2018-06-13 | 42266 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Resolved | 2018-08-22 | 2018-10-11 | 58777 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Resolved | 2019-02-05 | 2019-02-28 | 74781 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Actual shortage | 2023-10-02 | 2023-11-02 | 205826 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2022-04-14 | 2022-06-07 | 158877 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Actual shortage | 2023-11-17 | 2024-05-13 | 210671 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2017-11-30 | 2017-12-14 | 31386 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2020-12-25 | 130358 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2021-01-20 | 130361 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2018-02-15 | 2018-05-16 | 39961 |
| LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | 5MG 50MCG | SOLUTION | Actual shortage | 2023-06-06 | 2023-06-27 | 193838 |
| DIAZEPAM INJECTION USP | 5MG | SOLUTION | Resolved | 2018-09-27 | 2019-05-04 | 62442 |
| DIAZEPAM INJECTION USP | 5MG | SOLUTION | Actual shortage | 2020-05-20 | 2020-05-21 | 115413 |
| CEFUROXIME FOR INJECTION, USP | 7.5G | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-08-13 | 122225 |
| CEFUROXIME FOR INJECTION, USP | 750MG | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-10-31 | 122228 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2018-02-15 | 2018-03-08 | 39965 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2018-04-04 | 2018-04-27 | 44923 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
Showing 1 to 4 of 4